US Biosafety Initiative Responds to Proposed Foreign Investment Rules
PR Newswire
1h ago
Ai Focus
The US Biosafety Initiative stated that the US Treasury Department plans to implement rules related to the Comprehensive Foreign Investment National Security Act, which will extend restrictions on foreign investment to a wide range of biotechnology activities such as drug compound development, biosequencing, bioinformatics, and biomanufacturing technologies. The organization argued that these restrictions should be targeted at specific national security risks, while also avoiding unnecessary suppression of investment, slowing down innovation, or weakening the competitiveness of American companies.
Helpful
No.Help

US Biosafety Initiative responds to proposed foreign investment rules

Washington, October 23, 2026 / PRNewswire / -- The U.S. Treasury Department proposed regulations on Thursday to implement the Comprehensive Foreign Investment National Security Act ( Comprehensive Outbound Investment National Security , referred to as COINS Act ).

The proposal will expand the scope of U.S. foreign investment restrictions to include a wide range of biotechnology activities, such as drug compound development, biosequencing, bioinformatics, and biomanufacturing technologies. Under the proposed rules, the United States will prohibit certain investments in covered foreign entities engaged in these activities, including equity investments, certain financing arrangements, and joint ventures.

Jennifer Crook, Executive Director of the US Biosecurity Initiative ( American Biosecurity Initiative ), issued a statement regarding this:

The United States' leadership in the field of biotechnology is crucial for national security, economic competitiveness, and the ability to develop new drugs. It is important to prevent sensitive technologies from falling into the hands of foreign adversaries. At the same time, it is equally important to maintain America's capability to develop these technologies domestically and to ensure that patients have access to promising new therapies.

The proposed restrictions on biotechnology foreign investment by the Treasury Department must, while addressing specific national security risks, avoid unnecessarily hindering investment, slowing down innovation, or putting American companies at a competitive disadvantage. Maintaining America's leadership in the field of biotechnology must continue to be a core component of the national security strategy.

About ABI

The U.S. Biosecurity Initiative brings together experts from the fields of biotechnology, national defense, and intelligence to promote policies that can strengthen U.S. national security and its leadership in biotechnology.

Message source: American Biosecurity Initiative

Tip
$0
Like
0
Save
0
Views 13
HKWDB reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
CLARITY With the legislation stalled, can Congress pass encryption tax rules first?
After the Senate failed to advance the CLARITY bill in September, a group of Republican senators proposed the ADAPT bill on October 22, aiming to establish tax arrangements for stablecoin payments that meet certain criteria, network fees of $10 and below, and rules regarding wash trading. The House tax bill has already been passed by its committee, but both still need to go through their respective legislative processes, and the progress of tax legislation does not mean that the market structure framework has been implemented.
crypto.news
·2026-10-23 21:36:20
5
The University of Texas Athletic Department and McCombs School of Business launch Bevo Lab, focusing on sports, AI and data analysis
The University of Texas Athletic Department and McCombs School of Business announce the launch of Bevo Lab, in collaboration with Dell Technologies, Google Cloud, and SHI International, to create a platform focused on sports intelligence, data analysis, research, and talent development. This laboratory will focus on the integration of sports data, prediction AI models, and student practical training.
PR Newswire
·2026-10-23 21:26:03
15
Market Review
This week, the US dollar has been generally weak, with gold declining and crude oil strengthening. The US stock market has re-priced around the capital return rate of AI. News regarding companies such as Meta, SpaceX, Tesla, NVIDIA, and Anthropic has become focal points in the market. At the same time, political risks in France, the situation between Russia and Ukraine and in the Middle East, fluctuations in the South Korean stock market, and global cybersecurity vulnerabilities have also drawn attention.
金十数据
·2026-10-23 21:25:57
14
This Week's Bull Stocks in the US Market | Akafi Up More than 16% This Week, EPS Exceeds Expectations and Raises Full-Year Profit Margin Guidance; Zscaler Rises Nearly 15%, PHP Vulnerabilities Drive Up Demand for Cybersecurity; Thomson Reuters Up More than 13%, Launches Tax and Audit AI Solutions with Justifiable Basis
This week, the Dow Jones index rose by 1.66% cumulatively, the S&P 500 index remainedほぼ unchanged, and the Nasdaq Composite Index fell slightly. Ecolab strengthened due to EPS exceeding expectations, AI driving productivity improvements, and upward revisions to annual profit margin guidance; Zscaler was boosted by increased demand for cybersecurity triggered by a vulnerability in PHP and support for NVIDIA OpenShell architecture news; Thomson Reuters rose due to the launch of a new generation of tax, auditing, and accounting AI solutions.
The Block
·2026-10-23 21:15:58
17
Infosys calls differentiated AI strategy to drive a 29% month-on-month increase in AI revenue
Infosys Announces Second Quarter Results for Fiscal Year 2026 as of September 30: Revenue of $5.145 Billion, Up 1.5% Year-on-Year and 1.2% Quarter-on-Quarter at Fixed Exchange Rates; Operating Margin at 21.0%. The company stated that the total contract value of large orders reached $5.2 billion, of which 62% was new business. At the same time, it lowered its revenue growth guidance for fiscal year 2027 to 1% to 2%, while maintaining its profit margin guidance between 20% and 22%.
PR Newswire
·2026-10-23 21:15:56
17
View More